APO-SITAGLIPTIN TABLET Kanada - angličtina - Health Canada

apo-sitagliptin tablet

apotex inc - sitagliptin (sitagliptin phosphate monohydrate) - tablet - 50mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg

APO-SITAGLIPTIN TABLET Kanada - angličtina - Health Canada

apo-sitagliptin tablet

apotex inc - sitagliptin (sitagliptin phosphate monohydrate) - tablet - 100mg - sitagliptin (sitagliptin phosphate monohydrate) 100mg

XELEVIA sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

xelevia sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 128.9 mg (equivalent: sitagliptin, qty 100 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; sodium stearylfumarate; propyl gallate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - xelevia (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies.

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

xelevia sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 32.22 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; sodium stearylfumarate; propyl gallate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - xelevia (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies.

XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

xelevia sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 64.44 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; sodium stearylfumarate; magnesium stearate; propyl gallate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - xelevia (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies.

SITAGLIPTIN-METFORMIN TABLET Kanada - angličtina - Health Canada

sitagliptin-metformin tablet

sivem pharmaceuticals ulc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet - 50mg; 500mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 500mg

SITAGLIPTIN-METFORMIN TABLET Kanada - angličtina - Health Canada

sitagliptin-metformin tablet

sivem pharmaceuticals ulc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet - 50mg; 850mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 850mg

SITAGLIPTIN-METFORMIN TABLET Kanada - angličtina - Health Canada

sitagliptin-metformin tablet

sivem pharmaceuticals ulc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet - 50mg; 1000mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 1000mg

APO-SITAGLIPTIN/METFORMIN XR TABLET (EXTENDED-RELEASE) Kanada - angličtina - Health Canada

apo-sitagliptin/metformin xr tablet (extended-release)

apotex inc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet (extended-release) - 50mg; 500mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 500mg

APO-SITAGLIPTIN/METFORMIN XR TABLET (EXTENDED-RELEASE) Kanada - angličtina - Health Canada

apo-sitagliptin/metformin xr tablet (extended-release)

apotex inc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet (extended-release) - 50mg; 1000mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 1000mg